Ashland Global Holdings Inc. offers specialized chemical solutions globally. The company is headquartered in Covington, Kentucky.
| Revenue (TTM) | $1.86B |
| Gross Profit (TTM) | $601.00M |
| EBITDA | $293.00M |
| Operating Margin | 7.83% |
| Return on Equity | 1.33% |
| Return on Assets | 1.55% |
| Revenue/Share (TTM) | $40.50 |
| Book Value | $40.17 |
| Price-to-Book | 1.89 |
| Price-to-Sales (TTM) | 1.88 |
| EV/Revenue | 2.408 |
| EV/EBITDA | 15.26 |
| Quarterly Earnings Growth (YoY) | -47.50% |
| Quarterly Revenue Growth (YoY) | 4.40% |
| Shares Outstanding | $45.79M |
| Float | $37.95M |
| % Insiders | 1.18% |
| % Institutions | 117.53% |
Volatility is currently expanding
Ashland NYSE: ASH reported higher sales and adjusted earnings for its fiscal fourth quarter, as growth in pharmaceutical and personal care products helped offset weaker manufacturing productivity in Specialty Additives.
Sales of $498 million, up four percent from the prior-year quarter Loss from continuing operations of $17 million, or ($0.36) per diluted share Adjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $52 million, or $1.12 per diluted share Net loss of $16 million, or ($0.35) per diluted share Sales volumes rose three percent from the prior-year quarter, led by growth in Life Sciences and Personal Care Adjusted EBITDA of $121 million, up two percent from the prior-year quarter; strong growth in Life Sciences, Personal Care, and Intermediates was partially offset by lower earnings in Specialty Additives Cash flows provided by operating activities of $90 million; Ongoing Free Cash Flow2 of $74 million Issues outlook for full‑year fiscal 2027 sales of $1,905-$1,975 million and Adjusted EBITDA of $405-$435 million WILMINGTON, Del., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the fourth quarter of fiscal year 2026, which ended September 30, 2026, together with its fiscal year 2026 results summary and full-year fiscal 2027 outlook.
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WILMINGTON, Del., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fourth-quarter fiscal 2026 earnings release at approximately 5 p.m.
Ashland's shares have gained 30.2% in six months as cost cuts, portfolio optimization and a $1-billion buyback support returns.
Ashland Inc. (ASH) Analyst/Investor Day Transcript
Ashland is using cost savings, portfolio optimization and buybacks to strengthen margins and free cash flow despite tariff and demand headwinds.
Wilmington, Del., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host an Innovation Day webcast on September 17, 2026.
Ashland (ASH) reported earnings 30 days ago. What's next for the stock?
Ashland launches Permexa sodium caprate to support oral peptide and biologic development with enhanced processing and permeability.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ASH and any ticker you trade — then tracks every position and per-strategy win rate.
